Skip to main content

James Hambro & Partners

SEC CIK
0001731152
Latest filing
Jul 23, 2026

TMO holding history

Thermo Fisher Scientific Inc. in every 13F filed by James Hambro & Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TMO overviewAll 13F holders of TMOFull Q2 2026 holdings

Shares (Q2 2026)
229,471
Value
$114.9M
% of portfolio
4.2%
Quarters held
22
Since Q1 2021
Holdings of TMO by James Hambro & Partners, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026229,471$114.9M4.2%−11,238−4.7%ReducedHolders
Q1 2026240,709$118.4M4.6%−630−0.3%ReducedHolders
Q4 2025241,339$139.9M5.0%−8,393−3.4%ReducedHolders
Q3 2025249,732$121.1M4.3%−7,595−3.0%ReducedHolders
Q2 2025257,327$104.3M4.1%+22,904+9.8%AddedHolders
Q1 2025234,423$116.7M4.9%+12,219+5.5%AddedHolders
Q4 2024222,204$115.6M4.6%+12,751+6.1%AddedHolders
Q3 2024209,453$129.5M5.4%+11,276+5.7%AddedHolders
Q2 2024198,177$109.5M5.1%+5,213+2.7%AddedHolders
Q1 2024192,964$112.1M5.2%+5,071+2.7%AddedHolders
Q4 2023187,893$99.8M5.3%+16,594+9.7%AddedHolders
Q3 2023171,299$86.7M5.6%+13,937+8.9%AddedHolders
Q2 2023157,362$82.1M5.4%+8,193+5.5%AddedHolders
Q1 2023149,169$86.0M6.3%+2,896+2.0%AddedHolders
Q4 2022146,273$80.6M6.2%+559+0.4%AddedHolders
Q3 2022145,714$74.0M6.5%−4,263−2.8%ReducedHolders
Q2 2022149,977$81.6M6.8%−690.0%ReducedHolders
Q1 2022150,046$88.7M6.3%+181+0.1%AddedHolders
Q4 2021149,865$100.0M6.8%+464+0.3%AddedHolders
Q3 2021149,401$85.3M6.4%+7,866+5.6%AddedHolders
Q2 2021141,535$71.4M5.7%+10,286+7.8%AddedHolders
Q1 2021131,249$59.9M5.5%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.